About YMSLABS
YMSLABS is a company. The company has 55 employees as of April 08, 2024. YMSLABS offers products and services including Pyridine Derivatives and Pharmaceutical Bulk Drug Intermediates.
- Employees 55 as on 08 Apr, 2024
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
- Legal Name Y M S Laboratories Pvt. Ltd
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$1.58 M (USD)96.32as on Mar 31, 2022
-
Net Profit
$30.34 K (USD)65.53as on Mar 31, 2022
-
EBITDA
$167.72 K (USD)24.68as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
55
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of YMSLABS
YMSLABS offers a comprehensive portfolio of products and services, including Pyridine Derivatives and Pharmaceutical Bulk Drug Intermediates.
Pyridine derivatives are developed and scaled for pharmaceutical uses
Pharmaceutical bulk drug intermediates are optimized and manufactured for drug production processes
Funding Insights of YMSLABS
Detailed funding history for YMSLABS
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by YMSLABS
Investment portfolio details for YMSLABS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - YMSLABS
Detailed financials for YMSLABS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ymslabs Comparisons
Peer comparison for YMSLABS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of YMSLABS
Detailed competitors of YMSLABS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ymslabs
Complete news archive for YMSLABS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about YMSLABS
As of Apr 08, 2024, the latest employee count at YMSLABS is 55.
Annual revenue of YMSLABS is $1.58M as on Mar 31, 2022.
YMS Laboratories Pvt. Ltd. is noted for its emphasis on the development of new chemical entities, where optimization and scaling processes from gram to multi-ton scales are undertaken. The company was established in 2011 under the Indian Companies Act, 1956, with its registered office located in Hyderabad, Telangana, India, and manufacturing facilities positioned in Raichur, Karnataka, India. Research and development efforts are supported by dedicated centers, focusing on pyridine derivatives and pharmaceutical bulk drug intermediates to meet industry demands. Operational activities are managed through B2B models, ensuring compliance and efficiency in chemical production.
YMSLABS offers Pyridine Derivatives and Pharmaceutical Bulk Drug Intermediates.